期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (6)
Adoptive therapy with cytomegalovirus (CMV)-specific cytotoxic T lymphocytes (CMV-CTLs) has emerged as an effective method for CMV infection. However,......
期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (8)
We developed a T-cell-receptor (TCR) complex-based chimeric antigen receptor (CAR) named Synthetic TCR and Antigen Receptor (STAR). Here, we report pr......
期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (4)
Several studies reported hematological abnormalities after vaccination against the coronavirus disease 2019 (COVID-19). We evaluated the association b......
期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (1)
Individualized chemotherapy, which is at the forefront of acute myeloid leukemia (AML) treatment, has moderately improved outcomes over the past decad......
期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (5)
Few prospective studies have examined posttransplant chimeric antigen receptor (CAR) T cell infusion as candidates for front-line consolidation therap......
期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (7)
In this open-label, single-arm, phase I/II clinical trial, we evaluated the efficacy of anti-B cell maturation antigen (BCMA) chimeric antigen recepto......
期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (11)
Cytomegalovirus (CMV) infection remains a major cause of mortality after hematopoietic stem cell transplantation (HSCT). Current treatments, including......
期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (5)
Angioimmunoblastic T-cell lymphoma (AITL) is a common type of peripheral T-cell lymphoma (PTCL) with a poor prognosis, and an effective first-line the......
期刊: AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (4)
Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder, in which rituximab (RTX) induces the best long-term effect among recommended......